Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00325936
Status:
COMPLETED
Last Update Posted:
2008-08-27
First Post:
2006-05-12
Brief Title:
The Effects of Cilnidipine on Metabolic Syndrome Improvement
Sponsor:
Boryung Pharmaceutical Co Ltd
Organization:
Boryung Pharmaceutical Co Ltd
Study Overview
Official Title:
A Multi-Center Double-Blind Randomized Superiority Clinical Study to Compare the Effects of Cilnidipine on Metabolic Syndrome Improvement With Nifedipine GITS in Hypertensive Patients With Metabolic Syndrome Phase IV SLIMS
Status:
COMPLETED
Status Verified Date:
2008-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Abnormalities of glucose insulin and lipoprotein metabolism are common in patients with hypertension and these metabolic abnormalities are reported to be related to insulin resistance Therefore whenever treating such patients antihypertensive agents that may have the added effect of improving insulin resistance should be selected CinalongTM Cilnidipine is expected to improve metabolic syndrome as well as insulin resistance by its dual effects on L and N-type calcium Ca channels In this study the researchers investigate the effects of CinalongTM on insulin resistance and other metabolic related factors
Detailed Description:
Multi-center randomized prospective double blind active control parallel study
Superiority study Treatment group - CilnidipineControl group - Nifedipine
Measure the effects of CinalongTM after 3 month and 12 month-application
Superiority study Treatment group - CilnidipineControl group - Nifedipine
Measure the effects of CinalongTM after 3 month and 12 month-application
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| SLIMS study | None | None | None |